279 related articles for article (PubMed ID: 31058847)
1. Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors.
Liu C; Li P; Qu Z; Xiong W; Liu A; Zhang S
Molecules; 2019 May; 24(9):. PubMed ID: 31058847
[TBL] [Abstract][Full Text] [Related]
2. Dietary pretreatment with green tea polyphenol, (-)-epigallocatechin-3-gallate reduces the bioavailability and hepatotoxicity of subsequent oral bolus doses of (-)-epigallocatechin-3-gallate.
James KD; Forester SC; Lambert JD
Food Chem Toxicol; 2015 Feb; 76():103-8. PubMed ID: 25528115
[TBL] [Abstract][Full Text] [Related]
3. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
[TBL] [Abstract][Full Text] [Related]
4. The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
Mayr C; Wagner A; Neureiter D; Pichler M; Jakab M; Illig R; Berr F; Kiesslich T
BMC Complement Altern Med; 2015 Jun; 15():194. PubMed ID: 26100134
[TBL] [Abstract][Full Text] [Related]
5. Experimental study on anti-neoplastic activity of epigallocatechin-3-gallate to digestive tract carcinomas.
Ran ZH; Zou J; Xiao SD
Chin Med J (Engl); 2005 Aug; 118(16):1330-7. PubMed ID: 16157026
[TBL] [Abstract][Full Text] [Related]
6. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
Yamauchi R; Sasaki K; Yoshida K
Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
[TBL] [Abstract][Full Text] [Related]
7. Green tea polyphenol epigallocatechin-3-gallate (EGCG) as adjuvant in cancer therapy.
Lecumberri E; Dupertuis YM; Miralbell R; Pichard C
Clin Nutr; 2013 Dec; 32(6):894-903. PubMed ID: 23582951
[TBL] [Abstract][Full Text] [Related]
8. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
[TBL] [Abstract][Full Text] [Related]
9. Anticancer effects of (-)-epigallocatechin-3-gallate on ovarian carcinoma cell lines.
Huh SW; Bae SM; Kim YW; Lee JM; Namkoong SE; Lee IP; Kim SH; Kim CK; Ahn WS
Gynecol Oncol; 2004 Sep; 94(3):760-8. PubMed ID: 15350370
[TBL] [Abstract][Full Text] [Related]
10. An overview of pre-clinical studies on the effects of (-)-epigallocatechin-3-gallate, a catechin found in green tea, in treatment of pancreatic cancer.
Bimonte S; Cascella M; Leongito M; Palaia R; Caliendo D; Izzo F; Cuomo A
Recenti Prog Med; 2017 Jun; 108(6):282-287. PubMed ID: 28631776
[TBL] [Abstract][Full Text] [Related]
11. Green tea and cancer chemoprevention.
Suganuma M; Okabe S; Sueoka N; Sueoka E; Matsuyama S; Imai K; Nakachi K; Fujiki H
Mutat Res; 1999 Jul; 428(1-2):339-44. PubMed ID: 10518005
[TBL] [Abstract][Full Text] [Related]
12. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
[TBL] [Abstract][Full Text] [Related]
13. Biological and Mechanistic Characterization of Novel Prodrugs of Green Tea Polyphenol Epigallocatechin Gallate Analogs in Human Leiomyoma Cell Lines.
Ahmed RS; Liu G; Renzetti A; Farshi P; Yang H; Soave C; Saed G; El-Ghoneimy AA; El-Banna HA; Foldes R; Chan TH; Dou QP
J Cell Biochem; 2016 Oct; 117(10):2357-69. PubMed ID: 26950525
[TBL] [Abstract][Full Text] [Related]
14. (-)-Epigallocatechin gallate and polyphenon E inhibit growth and activation of the epidermal growth factor receptor and human epidermal growth factor receptor-2 signaling pathways in human colon cancer cells.
Shimizu M; Deguchi A; Lim JT; Moriwaki H; Kopelovich L; Weinstein IB
Clin Cancer Res; 2005 Apr; 11(7):2735-46. PubMed ID: 15814656
[TBL] [Abstract][Full Text] [Related]
15. Effects of dosing condition on the oral bioavailability of green tea catechins after single-dose administration of Polyphenon E in healthy individuals.
Chow HH; Hakim IA; Vining DR; Crowell JA; Ranger-Moore J; Chew WM; Celaya CA; Rodney SR; Hara Y; Alberts DS
Clin Cancer Res; 2005 Jun; 11(12):4627-33. PubMed ID: 15958649
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB.
Lee MH; Han DW; Hyon SH; Park JC
Apoptosis; 2011 Jan; 16(1):75-85. PubMed ID: 20963498
[TBL] [Abstract][Full Text] [Related]
17. Bioavailability and antioxidant effect of epigallocatechin gallate administered in purified form versus as green tea extract in healthy individuals.
Henning SM; Niu Y; Liu Y; Lee NH; Hara Y; Thames GD; Minutti RR; Carpenter CL; Wang H; Heber D
J Nutr Biochem; 2005 Oct; 16(10):610-6. PubMed ID: 16081270
[TBL] [Abstract][Full Text] [Related]
18. Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Lee SC; Chan WK; Lee TW; Lam WH; Wang X; Chan TH; Wong YC
Nutr Cancer; 2008; 60(4):483-91. PubMed ID: 18584482
[TBL] [Abstract][Full Text] [Related]
19. A novel prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate as a potential anticancer agent.
Landis-Piwowar KR; Huo C; Chen D; Milacic V; Shi G; Chan TH; Dou QP
Cancer Res; 2007 May; 67(9):4303-10. PubMed ID: 17483343
[TBL] [Abstract][Full Text] [Related]
20. Prodrug of green tea epigallocatechin-3-gallate (Pro-EGCG) as a potent anti-angiogenesis agent for endometriosis in mice.
Wang CC; Xu H; Man GC; Zhang T; Chu KO; Chu CY; Cheng JT; Li G; He YX; Qin L; Lau TS; Kwong J; Chan TH
Angiogenesis; 2013 Jan; 16(1):59-69. PubMed ID: 22948799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]